Concepedia

William Luther

WL

Statistics

Publications

6

Citations

1.5K

H-Index

6

Active since

2008

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Boston Children's Hospital

Memorial Sloan Kettering Cancer Center

William Luther is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and oncogenic signaling pathways.

Publications per year

2008–2015

6

Publications

6

Activating mutations in ALK provide a therapeutic target in neuroblastoma

Rani E. George, Takaomi Sanda, Megan Hanna et al. · Nature · 2008 · 892 citations · Full text

Medicine, Molecular Genetics, Oncology +12

The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma

Teeara Berry, William Luther, Namrata Bhatnagar et al. · Cancer Cell · 2012 · 327 citations · Full text

Medicine, Molecular Genetics, Oncology +14

ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT

David Debruyne, Namrata Bhatnagar, Bhawna Sharma et al. · Oncogene · 2015 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

Distinct Neuroblastoma-associated Alterations of PHOX2B Impair Sympathetic Neuronal Differentiation in Zebrafish Models

De‐Sheng Pei, William Luther, Wenchao Wang et al. · PLoS Genetics · 2013 · 74 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma

Wenqi Wang, Quan Zhong, Lisong Teng et al. · Oncogene · 2013 · 30 citations · Full text

Life Sciences, Cell Biology, Neuroscience +12

1–5 of 6